Ardea Biosciences (RDEA) Posts Q2 Loss of $0.49 Ex-Items, Misses Street Target
Tweet Send to a FriendGet Alerts RDEA Hot Sheet
Price: $31.96 --0%
Revenue Growth %: -15.3%
Financial Fact:
Total revenues: 1.48M
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -15.3%
Financial Fact:
Total revenues: 1.48M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade RDEA Now!
Ardea Biosciences, Inc. (Nasdaq: RDEA) reports Q2 EPS of $0.49, ex-items, versus the analyst estimate of ($0.12). Revenue for the quarter was $3.5 million, which compares to the estimate of $4.13 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Actuant Corp. (ATU) Tops Q3 EPS by 3c; Trims FY13 Outlook, Guides FY14
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
- Factset Research Systems (FDS) Reports In-Line Q3 EPS; Guides Q4 EPS, Revs
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
